Hybio Pharmaceutical Co., Ltd. (300199)
Market Open
16 Oct, 02:13 AM
XSHE XSHE Primary ¥
25. 51
+0.96
+3.9104%
¥
17.78B Market Cap
- P/E Ratio
0.8% Div Yield
39.41M Volume
- Eps
¥ 24.55
Previous Close Want to track 300199 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hybio Pharmaceutical Co., Ltd. (300199) Statistics
Valuation metrics
Market Cap 17.78B
Enterprise value 22.74B
Trailing P/E (ttm) 171.81
Forward P/E -
PEG ratio -0.12
Price/Sales (ttm) 18.95
Price/Book (mrq) 24.63
Enterprise Value/Revenue 20.58
Enterprise Value/EBITDA 66.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 57.78M
Average volume (90 days) 46.34M
Price summary
52-Week low 16.23
52-Week high 27.7
Beta -
50-Day moving average 23.25
200-Day moving average 22.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.75
Dividend Date -
Ex-Dividend Date -
Last split factor 20:10
Last split Date 14 Apr 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.25
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.17
Total debt (mrq) -
Total Debt/Equity (mrq) 2.3
Current ratio (mrq) 0.46%
Book value per share (mrq) 0.98
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
